| Today's Open | $14.42 |
|---|---|
| Previous Close | $14.50 |
| Daily Range | $14.33 - $15.36 |
| 52-Week Range | $9.86 - $31.21 |
| Market Cap | $1.5B |
| P/E Ratio | -8.29 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 3,715,693 |
| Average Daily Volume | 2,716,425 |
| Current FY EPS | -$1.91 |
Sector
Healthcare
Industry
Drugs
VIVUS, Inc. (VVUS) Description
A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. Website: http://www.vivus.com/
News & Commentary
Affecting more than 25 million people in the U.S., here are the primary factors that lead to this potentially debilitating disease and what's being done to curb its growth.
3 Humongous Health Care Stocks This Week
The major indexes might be tired after a great run this year, but these health-care stocks are sprinting ahead.
A mixture of cultural and socioeconomic factors make these seven U.S. states the healthiest.
VVUS's Top Competitors
(2.21%)
(-0.24%)
(-0.45%)
(0.61%)